Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle (2016)
- Authors:
- Autor USP: ROSA NETO, JOSÉ CESAR - ICB
- Unidade: ICB
- DOI: 10.1002/jcsm.12104
- Subjects: MÚSCULO ESQUELÉTICO; HIPERGLICEMIA; QUIMIOTERAPIA; INSULINA; GLICOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Cachexia, Sarcopenia and Muscle
- ISSN: 2190-6009
- Volume/Número/Paginação/Ano: v. 7, n. 5, p. 615-625, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LIMA JUNIOR, Edson Alves de et al. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, v. 7, n. 5, p. 615-625, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12104. Acesso em: 27 jan. 2026. -
APA
Lima Junior, E. A. de, Yamashita, A. S., Pimentel, G. D., Sousa, L. G. O. de, Santos, R. V. T. dos, Gonçalves, C. L., et al. (2016). Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, 7( 5), 615-625. doi:10.1002/jcsm.12104 -
NLM
Lima Junior EA de, Yamashita AS, Pimentel GD, Sousa LGO de, Santos RVT dos, Gonçalves CL, Streck EL, Lira FS de, Rosa Neto JC. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2016 ; 7( 5): 615-625.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1002/jcsm.12104 -
Vancouver
Lima Junior EA de, Yamashita AS, Pimentel GD, Sousa LGO de, Santos RVT dos, Gonçalves CL, Streck EL, Lira FS de, Rosa Neto JC. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2016 ; 7( 5): 615-625.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1002/jcsm.12104 - Type and intensity as key variable of exercise in metainflammation diseases: a review
- Is palmitoleic acid a plausible nonpharmacological strategy to prevent or control chronic metabolic and inflammatory disorders?
- Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice
- Palmitoleic acid improves metabolic functions in fatty liver by PPARα-dependent AMPK activation
- Corrigendum: Editorial: Cross-talk between heterogeneous cell types in skeletal muscle: implications for glucose metabolism
- Beta-Alanine supplementation improved 10-km running time trial in physically active adults
- "Palmitoleic acid has stronger anti-inflammatory potential in human endothelial cells compared to oleic and palmitic acids"
- Levels of cardiorespiratory fitness in men exerts strong impact on lymphocyte function after mitogen stimulation
- Gut-central nervous system axis is a target for nutritional therapies
- Effect of an acute moderate-exercise session on metabolic and inflammatory profile of PPAR-α knockout mice
Informações sobre o DOI: 10.1002/jcsm.12104 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
